Riskpilot← Back to searchSign inGet full accessCorline Biomedical AB
ABActiveOrg 5564170743Lefflersgatan 5Research and experimental development on natural sciences and engineering · NACE 7210Est. 199113 employees
Revenue 2024
SEK 9,8M
-61% vs 2023
EBITDA margin
-236.0%
-1264% vs 2023
Equity ratio
91.7%
Financial strength
Net profit 2024
SEK -23,2M
-1182% vs 2023
| Revenue | SEK 9,8M | -61% |
| EBITDA | SEK -23,1M | -1264% |
| Net profit | SEK -23,2M | -1182% |
| Total assets | SEK 94,8M | -5% |
| Equity | SEK 86,9M | -7% |
| Employees | 13 | — |
Legal name
Corline Biomedical AB
Org number
5564170743
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
24 januari 1991
Share capital
SEK 3 061 000
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Nittmar, Bror Lars Henrik i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall självt eller genom dotterbolag och samarbetande bolag utveckla, tillverka och marknadsföra medicintekniska produkter samt idka därmed förenlig verksamhet.
Address
Lefflersgatan 5
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 696 | 7 062 | 23 550 | 25 030 | 9 775 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −7 273 | −6 878 | 2 385 | −1 691 | −23 071 |
| Depreciation & amort. | −14 | −31 | −56 | −97 | −95 |
| EBIT | −7 287 | −6 909 | 2 329 | −1 788 | −23 166 |
| Net financials | — | −13 | — | −21 | −28 |
| Profit before tax | −7 285 | −6 922 | 2 329 | −1 809 | −23 194 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −7 285 | −6 922 | 2 329 | −1 809 | −23 194 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 58 455 | 101 661 | 101 783 | 100 105 | 94 762 |
| Equity | 52 215 | 92 234 | 94 589 | 93 316 | 86 914 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 6 240 | 9 427 | 7 194 | 6 789 | 7 848 |
| Total debt | 6 240 | 9 427 | 7 194 | 6 789 | 7 848 |
EBITDA margin
-236.0%
This company
15.8%
Market median
-1594% vs market
20202024
Equity ratio
91.7%
This company
38.2%
Market median
+140% vs market
20202024
Return on equity
-26.7%
This company
18.4%
Market median
-245% vs market
20202024
Net profit margin
-237.3%
This company
8.1%
Market median
-3030% vs market
20202024
Asset turnover
0.10×
This company
1.12×
Market median
-91% vs market
20202024
Debt / equity
0.09×
This company
0.62×
Market median
+85% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LG Chief Auditor | Chief Auditor | 2020 |
BL Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Board of Directors | 2020 | |
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2022 | |
| Former (2) | ||
| Board of Directors | 2020 – 2021 | |
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Corline Biomedical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Gustaf Kylberg | Chief Auditor | 0 companies |
| Bror Lars Henrik Nittmar | Chief Executive Officer | 0 companies |
| Ylva Gunilla Ekström | Board of Directors | 0 companies |
| Kerstin B Valinder Strinnholm | Board of Directors | 0 companies |
| Tomas Peter Lifvendahl | Board of Directors | 0 companies |
| Leif Henrik Krook | Board of Directors | 0 companies |
| Lars Fredrik Sunnanväder | Board of Directors | 0 companies |
| Annika Sunnanväder | Deputy Board Member | 0 companies |
| Lars Adam Holger Dahlberg | Chairman | 0 companies |
| Magnus Henrik Ludvig Nilsson | Board of Directors | 0 companies |